Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Timmermans

Showing results (1-10 of 292) with videos related to

Pageof 30
Sort By:
The Canadian Journal of Cardiology|December 1, 1999
Pharmacological properties of angiotensin II receptor antagonistsP B Timmermans
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 16, 1999
Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeuticsP B Timmermans
Blood Pressure. Supplement|January 1, 1996
The diversified pharmacology of angiotensin II-receptor blockadeP B Timmermans, R D Smith
Blood Pressure. Supplement|January 1, 1996
Historical development of losartan (DuP 753) and angiotensin II receptor subtypesP C Wong, P B Timmermans
Current Opinion in Nephrology and Hypertension|January 1, 1994
Human angiotensin receptor subtypesR D Smith, P B Timmermans
Hypertension (Dallas, Tex. : 1979)|November 1, 1986
Biotechnology and the pharmaceutical industry. New cardiovascular drugsM D Dibner, P B Timmermans
European Journal of Pharmacology|August 11, 1987
Equal potency of nifedipine to inhibit alpha 1-(dobutamine and BDF 6143) and alpha 2-adrenoceptor (B-HT 920) induced pressor responses in pithed rats; lack of effect of phenoxybenzamineP B Timmermans, M J Thoolen
European Heart Journal|December 1, 1994
Angiotensin II receptor subtypes: selective antagonists and functional correlatesP B Timmermans, R D Smith
Medicinal Research Reviews|July 1, 1987
Autoreceptors in the central nervous systemP B Timmermans, M J Thoolen
Cardiologia (Rome, Italy)|December 1, 1994
A new class of therapeutic agents: the angiotensin II receptor antagonistsP B Timmermans, R D Smith
Pageof 30

Showing results (1-10 of 292) with videos related to

Sort By:
Pageof 30
The Canadian Journal of Cardiology|December 1, 1999
Pharmacological properties of angiotensin II receptor antagonistsP B Timmermans
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 16, 1999
Angiotensin II receptor antagonists: an emerging new class of cardiovascular therapeuticsP B Timmermans
Blood Pressure. Supplement|January 1, 1996
The diversified pharmacology of angiotensin II-receptor blockadeP B Timmermans, R D Smith
Blood Pressure. Supplement|January 1, 1996
Historical development of losartan (DuP 753) and angiotensin II receptor subtypesP C Wong, P B Timmermans
Current Opinion in Nephrology and Hypertension|January 1, 1994
Human angiotensin receptor subtypesR D Smith, P B Timmermans
Hypertension (Dallas, Tex. : 1979)|November 1, 1986
Biotechnology and the pharmaceutical industry. New cardiovascular drugsM D Dibner, P B Timmermans
European Journal of Pharmacology|August 11, 1987
Equal potency of nifedipine to inhibit alpha 1-(dobutamine and BDF 6143) and alpha 2-adrenoceptor (B-HT 920) induced pressor responses in pithed rats; lack of effect of phenoxybenzamineP B Timmermans, M J Thoolen
European Heart Journal|December 1, 1994
Angiotensin II receptor subtypes: selective antagonists and functional correlatesP B Timmermans, R D Smith
Medicinal Research Reviews|July 1, 1987
Autoreceptors in the central nervous systemP B Timmermans, M J Thoolen
Cardiologia (Rome, Italy)|December 1, 1994
A new class of therapeutic agents: the angiotensin II receptor antagonistsP B Timmermans, R D Smith
Pageof 30